Urinary bladder cancer is more likely to be fatal in women than in men. With a male-to-female incidence ratio of approximately three to one, for women, the disease becomes fatal at a much earlier stage. The relative five-year survival rate for women is 72%(1) – corresponding to a ten-year survival rate for men. One of the reasons for the lower survival rate in women is inadequate early detection. On average, bladder cancer in women is diagnosed six to nine months later than in men(2).